Ólafur Gísli Jónsson

Risk group assignment differs for children and adults 1–45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL‐2008 protocol

Nina Toft, Henrik Birgens, Jonas Abrahamsson et al. · European Journal Of Haematology · 2013 · 138 citations

Medicine, Oncology, Pediatrics +6

Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

Bendik Lund, Ann Åsberg, Mats Heyman et al. · Pediatric Blood & Cancer · 2010 · 127 citations

Medicine, Hematology, Oncology +17

Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004

Henrik Hasle, Jonas Abrahamsson, Erik Forestier et al. · Blood · 2012 · 109 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

Stine Nygaard Nielsen, Kathrine Grell, Jacob Nersting et al. · The Lancet Oncology · 2017 · 109 citations

Medicine, Oncology, Pediatrics +13

Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years

Cecilie Utke Rank, Nina Toft, Ruta Tuckuviene et al. · Blood · 2018 · 109 citations · Full text

Medicine, Hematology, Oncology +14